FIGURE 6.
(A) Xenograft models inoculation with SK-N-SH cell transfected with siNKAP or siNC. (B) Xenograft tumors of SK-N-SH cell at 33 days after inoculation with siNKAP and siNC subcutaneously and the growth curves of xenograft models. (C) Function verification of NKAP in PI3K/AKT pathway by Western blot assay in vivo. (D) Quantification of NKAP function in PI3K/AKT pathway. ***P < 0.001, *P < 0.05.